The European Commission (EC) has approved OPUVIZ 40 mg/mL solution for injection in a vial. OPUVIZ is a biosimilar referencing Eylea (aflibercept). The biosimilar has been developed and registered by ...
The European Commission (EC) has approved OPUVIZ 40 mg/mL solution for injection in a vial. OPUVIZ is a biosimilar ...
Biogen (BIIB) is down more than -1% after Needham downgraded ... the stock to underperform from hold with a price target of $164. AECOM (ACM), BellRing Brands Inc (BRBR), Bit Digital Inc (BTBT), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback